HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Valent Selected Research

Mast-Cell Leukemia (Leukemia, Mast Cell)

1/2018SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.
12/2001Expression, epitope analysis, and functional role of the LFA-2 antigen detectable on neoplastic mast cells.
5/2001Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Valent Research Topics

Disease

19Neoplasms (Cancer)
01/2021 - 05/2000
18Systemic Mastocytosis
01/2018 - 08/2000
16Hypersensitivity (Allergy)
01/2019 - 04/2000
16Mastocytosis
10/2014 - 05/2000
12Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2021 - 04/2001
8Leukemia
10/2021 - 05/2000
6Seasonal Allergic Rhinitis (Hay Fever)
01/2018 - 09/2003
5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2017 - 10/2001
4Disease Progression
10/2020 - 05/2008
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 10/2001
3Mast-Cell Leukemia (Leukemia, Mast Cell)
01/2018 - 05/2001
3Eosinophilia
01/2017 - 01/2006
3Asthma (Bronchial Asthma)
06/2008 - 09/2001
3Ring Chromosomes (Ring Chromosome)
09/2001 - 04/2000
2Mastocytoma
12/2017 - 07/2012
2Splenomegaly
12/2016 - 07/2001
2Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
11/2016 - 05/2002
2Mast Cell Activation Syndrome
07/2014 - 04/2013
2Hematologic Neoplasms (Hematological Malignancy)
01/2012 - 08/2009
2Cytopenia
01/2010 - 05/2003
2Infections
12/2009 - 10/2009
2Myeloproliferative Disorders (Myeloproliferative Disorder)
10/2009 - 04/2006
2Iron Overload
05/2009 - 03/2008
2Inflammation (Inflammations)
03/2009 - 08/2000
2Myeloid Leukemia (Leukemia, Myelocytic)
03/2009 - 10/2001
2Crohn Disease (Crohn's Disease)
04/2002 - 03/2001
2Ulcerative Colitis
04/2002 - 03/2001
1Hemolysis
10/2020
1Hematologic Diseases (Blood Diseases)
10/2020
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
10/2020
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
11/2017
1Atherosclerosis
11/2017
1Ischemia
11/2017
1Cutaneous Mastocytosis
01/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2017
1Blast Crisis (Blast Phase)
01/2016
1Anaphylaxis (Anaphylactic Shock)
07/2014
1Pdgfra-Associated Chronic Eosinophilic Leukemia
06/2013

Drug/Important Bio-Agent (IBA)

21Immunoglobulin E (IgE)IBA
01/2019 - 04/2000
17AllergensIBA
01/2019 - 04/2000
15Tryptases (Tryptase)IBA
10/2014 - 05/2000
14AntibodiesIBA
01/2019 - 08/2000
7AntigensIBA
10/2007 - 05/2001
6Imatinib Mesylate (Gleevec)FDA Link
11/2017 - 01/2006
6VaccinesIBA
06/2012 - 09/2001
4Pharmaceutical PreparationsIBA
11/2015 - 03/2008
4Peptides (Polypeptides)IBA
06/2012 - 09/2001
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2010 - 04/2001
4Immunoglobulin G (IgG)IBA
08/2006 - 04/2002
3CytokinesIBA
12/2017 - 05/2003
3Stem Cell FactorIBA
12/2017 - 01/2000
3Phosphotransferases (Kinase)IBA
11/2017 - 03/2009
3Biological ProductsIBA
04/2013 - 05/2000
3Proteins (Proteins, Gene)FDA Link
04/2009 - 04/2000
3Chymases (Chymase)IBA
10/2007 - 02/2003
3ParaffinIBA
04/2006 - 08/2000
2Complement System Proteins (Complement)IBA
10/2020 - 08/2006
2Interleukin-13IBA
12/2017 - 02/2009
2Tyrosine Kinase InhibitorsIBA
01/2017 - 07/2012
2midostaurinIBA
02/2016 - 11/2009
2P-2 (P 2)IBA
02/2014 - 09/2003
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2012 - 01/2006
2bcr-abl Fusion ProteinsIBA
01/2010 - 03/2009
2Dasatinib (BMS 354825)FDA Link
12/2009 - 11/2008
2B-Lymphocyte Epitopes (B-Cell Epitope)IBA
10/2004 - 09/2001
2Immunoglobulin M (IgM)IBA
09/2003 - 08/2000
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2003 - 05/2001
2AutoantigensIBA
04/2002 - 03/2001
2Immunoglobulin A (IgA)IBA
04/2002 - 03/2001
2EpitopesIBA
12/2001 - 03/2001
2Peroxidase (Myeloperoxidase)IBA
05/2001 - 05/2000
2Ribosomal DNA (rDNA)IBA
01/2001 - 04/2000
2chloroacetate esteraseIBA
08/2000 - 05/2000
1Core Binding Factors (Core-Binding Factor)IBA
10/2021
1eculizumabFDA Link
10/2020
1Histone MethyltransferasesIBA
01/2018
1Omalizumab (Xolair)FDA Link
01/2018
1Histones (Histone)IBA
01/2018
1Lysine (L-Lysine)FDA Link
01/2018
1Interleukin-6 (Interleukin 6)IBA
12/2017
1Interleukin-2 (IL2)IBA
12/2017
1Interleukin-5 (Interleukin 5)IBA
12/2017
1Interleukin-4 (Interleukin 4)IBA
12/2017
1nilotinibFDA Link
11/2017
1Apolipoproteins E (ApoE)IBA
11/2017
1ibrutinibIBA
11/2017
1AngiopoietinsIBA
11/2017
1Tyrosine (L-Tyrosine)FDA Link
10/2017
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
01/2017
1Alkaline PhosphataseIBA
12/2016
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2016
1fms-Like Tyrosine Kinase 3IBA
02/2016
1CGP 52421IBA
02/2016
1CGP 62221IBA
02/2016
1hydrogen sulfite (bisulfite)IBA
01/2016
1Arthropod VenomsIBA
07/2014
1Oncostatin MIBA
06/2013

Therapy/Procedure

14Therapeutics
01/2021 - 07/2000
7Immunotherapy
06/2012 - 04/2000
1Intranasal Administration
01/2018